189 related articles for article (PubMed ID: 32635183)
1. Identification of miRNA Master Regulators in Breast Cancer.
Martinez-Gutierrez AD; Cantú de León D; Millan-Catalan O; Coronel-Hernandez J; Campos-Parra AD; Porras-Reyes F; Exayana-Alderete A; López-Camarillo C; Jacobo-Herrera NJ; Ramos-Payan R; Pérez-Plasencia C
Cells; 2020 Jul; 9(7):. PubMed ID: 32635183
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel lncRNA-miRNA-mRNA competing endogenous RNA network associated with prognosis of breast cancer.
Wan X; Hao S; Hu C; Qu R
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23089. PubMed ID: 35532246
[TBL] [Abstract][Full Text] [Related]
8. miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review).
Mu H; Zhang W; Qiu Y; Tao T; Wu H; Chen Z; Xu G
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760165
[TBL] [Abstract][Full Text] [Related]
9. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
10. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
Bottai G; Diao L; Baggerly KA; Paladini L; Győrffy B; Raschioni C; Pusztai L; Calin GA; Santarpia L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106823
[TBL] [Abstract][Full Text] [Related]
11. Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
He K; Li WX; Guan D; Gong M; Ye S; Fang Z; Huang JF; Lu A
Funct Integr Genomics; 2019 Jul; 19(4):645-658. PubMed ID: 30859354
[TBL] [Abstract][Full Text] [Related]
12. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
13. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.
Yin X; Wang P; Yang T; Li G; Teng X; Huang W; Yu H
Aging (Albany NY); 2020 Dec; 13(2):2519-2538. PubMed ID: 33318294
[TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
An M; Zang X; Wang J; Kang J; Tan X; Fu B
Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
[TBL] [Abstract][Full Text] [Related]
16. Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes.
Bhattacharyya M; Nath J; Bandyopadhyay S
Mol Biol Rep; 2016 Jul; 43(7):591-9. PubMed ID: 27245063
[TBL] [Abstract][Full Text] [Related]
17. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
18. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
19. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
